HEAD AND NECK NEOPLASMS
Clinical trials for HEAD AND NECK NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK NEOPLASMS trials appear
Sign up with your email to follow new studies for HEAD AND NECK NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug combo for head and neck cancer shows early promise
Disease control TerminatedThis early-stage trial tested an experimental drug called xevinapant combined with standard chemotherapy and radiation in people with head and neck cancer who cannot take the usual drug cisplatin. The goal was to find the safest dose of xevinapant. The study was terminated early,…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Targeted pill shows promise for rare lung cancer, but trial stopped early
Disease control TerminatedThis phase 3 study tested a new drug called pralsetinib against standard chemotherapy for people with a specific type of advanced lung cancer that has a RET gene fusion. The goal was to see if pralsetinib could better delay cancer growth. The trial was terminated early, so full r…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Tiny study uses PET scans to track cancer drug in tumors
Knowledge-focused TerminatedThis early-phase study aimed to use PET imaging to track how a new drug (BI 754111) spreads in the body and reaches tumors in people with advanced non-small cell lung cancer or head and neck cancer. Only 8 participants were planned, and the study was terminated early. The main go…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC